SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

  • This share is currently suspended. It was suspended at a price of 398.00
  • There is currently no data for TYMN

AGM Trading Statement

16 May 2024 07:00

RNS Number : 6169O
Tyman PLC
16 May 2024
 

TYMAN PLC

Annual General Meeting Trading Update

Tyman plc ("Tyman" or the "Group"), a leading international supplier of engineered fenestration components and access solutions to the construction industry, provides an update on trading for the period from 1 January 2024 to 30 April 2024 ("the period"), ahead of the Group's Annual General Meeting being held today at 10.30 a.m. at the offices of Latham & Watkins, 99 Bishopsgate, London, EC2M 3XF.

Current trading

Group revenue for the period decreased by 5% to £205 million on a reported basis, and by 4% on a like-for-like ("LFL") basis. The decrease in LFL revenue reflects, as expected, a continuation of the challenging market conditions experienced throughout 2023, during what is a seasonally less important period.

Tyman's financial performance continues to benefit from a contribution from Lawrence Industries, as well as the impact of previously announced self-help measures. The Group is continuing to progress its strategic initiatives, including activities to grow market share, the roll-out of the new ERP system across North America, and preparation for the consolidation of two sites into one in Owatonna.

Pending transaction with Quanex

The transaction with Quanex announced on 22 April 2024 is currently expected to become effective during the second half of 2024, subject to shareholder approval, regulatory approvals, and other customary conditions to the implementation of the transaction. Additional information on the pending transaction is available on Tyman's website at www.tymanplc.com/investor-relations/recommended-offer-for-tyman-by-quanex.

Rutger Helbing, Chief Executive Officer, commented:

"The Group continues to perform well against a subdued market backdrop and, whilst leading indicators for our major markets continue to signal a challenging near-term market outlook, the Board continues to expect the Group to make progress in 2024.

The structural growth drivers for the Group remain attractive and our market-leading brands and differentiated portfolio of products leave Tyman well placed for the longer term. Our focus remains on taking market share and implementing our self-help measures whilst investing in the business for the future."

16 May 2024

Enquiries

Tyman plc (investor.relations@tymanplc.com, 0207 9768000)

Rutger Helbing - Chief Executive Officer

Jason Ashton - Chief Financial Officer

Matt Jones - Head of Investor Relations

 

MHP (tyman@mhpgroup.com, 07801 894 577)

Reg Hoare / Rachel Farrington

 

Notes to editors

Tyman (TYMN: LSE) is a leading international supplier of engineered fenestration components and access solutions to the construction industry. The company designs and manufactures products that enhance the comfort, sustainability, security, safety and aesthetics of residential homes and commercial buildings. Tyman's portfolio of leading brands serve their markets through three divisions: Tyman North America, Tyman UK and Ireland and Tyman International. Headquartered in London, the Group employs approximately 3,600 people with facilities in 15 countries worldwide. Further information is available at www.tymanplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTAAMFTMTJBBLI
Date   Source Headline
23rd Apr 202411:53 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:45 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:41 amPRNForm 8.3 - Tyman plc
23rd Apr 202411:35 amRNSForm 8.5 (EPT/RI) - Tyman Plc
23rd Apr 202411:32 amRNSForm 8.3 -Quanex Building Products Corporation
23rd Apr 202411:29 amRNSForm 8.3 - Tyman plc
23rd Apr 202410:49 amRNSForm 8.5 (EPT/RI) - Tyman Plc
22nd Apr 20242:59 pmRNSForm 8.3 - Quanex Building Products Corporation
22nd Apr 20242:57 pmRNSForm 8.3 - Tyman plc
22nd Apr 202412:01 pmPRNForm 8.3 - Tyman plc
22nd Apr 20247:00 amRNSRecommended Cash and Share Offer
17th Apr 202411:22 amRNSHolding(s) in Company
28th Mar 20247:00 amRNS2023 Annual Report & Notice of AGM
7th Mar 20247:00 amRNSFinal Results
31st Jan 20247:00 amRNSNotice of Results
10th Jan 20248:00 amRNSDirector Declaration
27th Nov 20236:17 pmRNSDirector/PDMR Shareholding
27th Nov 20237:00 amRNSAppointment of new CEO
20th Nov 20232:00 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTrading Statement
31st Oct 20237:00 amRNSCapital Markets Event
2nd Oct 20237:00 amRNSNotice of Capital Markets Event
25th Jul 20237:00 amRNSHalf-year Report
12th Jul 20235:00 pmRNSAcquisition of Lawrence Industries
8th Jun 20239:21 amRNSHolding(s) in Company
1st Jun 20237:00 amRNSSBTi approval of carbon reduction targets
31st May 20237:00 amRNSDirectorate Changes
26th May 202310:59 amRNSDirector/PDMR Shareholding
19th May 202310:24 amRNSDirector/PDMR Shareholding
18th May 20231:30 pmRNSResult of AGM
18th May 20237:00 amRNSAGM Trading Update
21st Apr 20237:00 amRNSAppointment of Interim Chief Financial Officer
21st Apr 20237:00 amRNSDirector/PDMR Shareholding
6th Apr 20233:10 pmRNSAGM Update - Withdrawal of AGM Resolution
6th Apr 20237:00 amRNSDirectorate Change
3rd Apr 20237:00 amRNSAnnual Financial Report
30th Mar 20239:10 amRNSDirector/PDMR Shareholding
24th Mar 20231:34 pmRNSHolding(s) in Company
22nd Mar 20234:30 pmRNSDirector/PDMR Shareholding
14th Mar 20234:16 pmRNSDirector/PDMR Shareholding
3rd Mar 20235:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNotice of Results
28th Dec 20223:53 pmRNSHolding(s) in Company
15th Dec 202210:59 amRNSHolding(s) in Company
14th Dec 202212:00 pmRNSRefinancing of Debt Facilities
28th Nov 20223:30 pmRNSHolding(s) in Company
17th Nov 20227:00 amRNSTrading Statement
18th Oct 202212:00 pmRNSHolding(s) in Company
6th Oct 20223:41 pmRNSTR-1 Replacement: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.